GENOCEA BIOSCIENCES INC - COM NEW (GNCA)

CUSIP: 372427401

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class
Equity / COM NEW
Total 13F shares
33,642,363
Share change
+113,585
Total reported value
$42,053,171
Put/Call ratio
12%
Price per share
$1.25
Number of holders
40
Value change
+$144,477
Number of buys
14
Number of sells
10

Quarterly Holders Quick Answers

What is CUSIP 372427401?
CUSIP 372427401 identifies GNCA - GENOCEA BIOSCIENCES INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of GENOCEA BIOSCIENCES INC - COM NEW (GNCA) as of Q1 2022

As of 31 Mar 2022, GENOCEA BIOSCIENCES INC - COM NEW (GNCA) was held by 40 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 33,642,363 shares. The largest 10 holders included NEA Management Company, LLC, Avoro Capital Advisors LLC, BVF INC/IL, COMMODORE CAPITAL LP, Point72 Asset Management, L.P., KINGDON CAPITAL MANAGEMENT, L.L.C., CITADEL ADVISORS LLC, VANGUARD GROUP INC, BOXER CAPITAL, LLC, and ABG Innovation Capital Partners III GP Ltd. This page lists 40 institutional shareholders reporting positions in this security for the Q1 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.